BlackRock Institutional Trust’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$18.2M Buy
961,157
+12,102
+1% +$229K ﹤0.01% 2032
2016
Q3
$21.2M Buy
949,055
+43,660
+5% +$977K ﹤0.01% 1853
2016
Q2
$16.1M Buy
905,395
+15,914
+2% +$283K ﹤0.01% 1983
2016
Q1
$12.2M Buy
889,481
+60,801
+7% +$831K ﹤0.01% 2137
2015
Q4
$16M Buy
828,680
+69,375
+9% +$1.34M ﹤0.01% 2015
2015
Q3
$15.4M Buy
759,305
+92,176
+14% +$1.87M ﹤0.01% 2010
2015
Q2
$22.1M Buy
667,129
+159,263
+31% +$5.28M ﹤0.01% 1855
2015
Q1
$12.2M Buy
507,866
+191,961
+61% +$4.6M ﹤0.01% 2271
2014
Q4
$3.87M Buy
315,905
+112,853
+56% +$1.38M ﹤0.01% 2821
2014
Q3
$1.83M Sell
203,052
-19,287
-9% -$174K ﹤0.01% 3106
2014
Q2
$2.61M Buy
222,339
+38,173
+21% +$448K ﹤0.01% 3066
2014
Q1
$3.9M Buy
+184,166
New +$3.9M ﹤0.01% 2874